Zufika Qamar, Ali Sartaj, Mohammad Kashif Iqubal, Farheen Fatima Qizilbash, Suhaira Sabir, Javed Ali, Asgar Ali & Sanjula Baboota. (2023) Combination drug loaded lipid-based nanocarriers as treatment entity for battling glioblastoma multiforme. Journal of Drug Delivery Science and Technology 87, pages 104800.
Crossref
Rahul Shukla, Ajit Singh & Kamalinder K. Singh. (2023) Vincristine-based nanoformulations: a preclinical and clinical studies overview. Drug Delivery and Translational Research.
Crossref
Mehrab Pourmadadi, Amin Shamsabadipour, Atiya Bhatti, Mahboobeh Forouzanfar, Mohaddeseh Rajabnejad, Razieh Behzadmehr, Abbas Rahdar, Dora Iliana Medina & Ana M. Díez-Pascual. (2023) Therapeutic performance of temozolomide-loaded nanomaterials: A state-of-the-art. Journal of Drug Delivery Science and Technology 85, pages 104568.
Crossref
Manasa Manjunath Hegde, Puja Sandbhor, Aishwarya J.Vikram Gota & Jayant S. Goda. (2023) Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects. Frontiers in Oncology 13.
Crossref
Mahfoozur Rahman, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Majed Alrobaian, Md. Abul Barkat, Shehla Nasar Mir Najib Ullah, Waleed H. Almalki, Tanuja Singh, Sarwar Beg & Hani Choudhry. (2022) Paclitaxel and Curcumin as Dual-Drug-Loaded Lipid Nanocapsules in the Management of Brain Tumour. Journal of Cluster Science 34:4, pages 1927-1938.
Crossref
Tanisha Gupta, Rakesh K. Sahoo, Himani Singh, Sumeet Katke, Akash Chaurasiya & Umesh Gupta. (2023) Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities. AAPS PharmSciTech 24:4.
Crossref
Pablo Graván, Aixa Aguilera-Garrido, Juan Antonio Marchal, Saúl A. Navarro-Marchal & Francisco Galisteo-González. (2023) Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment. Advances in Colloid and Interface Science 314, pages 102871.
Crossref
Mona Basha, Mona M. AbouSamra & Rabab Kamel. 2023. Green Sustainable Process for Chemical and Environmental Engineering and Science. Green Sustainable Process for Chemical and Environmental Engineering and Science
109
126
.
Jivesh Garg, Khushboo Pathania, Sangeeta Pilkhwal Sah & Sandip V. Pawar. (2022) Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Margarita E. Neganova, Yulia R. Aleksandrova, Olga A. Sukocheva & Sergey G. Klochkov. (2022) Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Seminars in Cancer Biology 86, pages 805-833.
Crossref
Luyao Wang, Youyuan Shi, Jingzhen Jiang, Chan Li, Hengrui Zhang, Xinhui Zhang, Tao Jiang, Liang Wang, Yinyan Wang & Lin Feng. (2022) Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy. Small 18:45.
Crossref
Reena Jatyan, Prabhjeet Singh, Deepak Kumar Sahel, Y.G. Karthik, Anupama Mittal & Deepak Chitkara. (2022) Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme. Journal of Controlled Release 350, pages 494-513.
Crossref
Shumin Li, Zhongkai Xu, Majed Alrobaian, Obaid Afzal, Imran Kazmi, Waleed H. Almalki, Abdulmalik Saleh Alfawaz Altamimi, Fahad A. Al‐Abbasi, Khalid S Alharbi, Waleed M Altowayan, Tanuja Singh, Md Habban Akhter, Manish Gupta, Mahfoozur Rahman & Sarwar Beg. (2021) EGF‐functionalized lipid–polymer hybrid nanoparticles of 5‐fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma. Biotechnology and Applied Biochemistry 69:5, pages 2205-2221.
Crossref
Amit Kumar Singh, Prabhat Kumar Upadhyay & Manish Kumar. (2022) Viability of Nanostructured Lipid Carrier System in Overcoming the
Barriers Associated with Chemotherapeutic Delivery. Current Nanoscience 18:5, pages 587-603.
Crossref
Tejashree Waghule, Ranendra Narayan Saha, Amit Alexander & Gautam Singhvi. (2022) Tailoring the multi-functional properties of phospholipids for simple to complex self-assemblies. Journal of Controlled Release 349, pages 460-474.
Crossref
Sarah Lastakchi, Mary Kanyinsola Olaloko & Christopher McConville. (2022) A Potential New Treatment for High-Grade Glioma: A Study Assessing Repurposed Drug Combinations against Patient-Derived High-Grade Glioma Cells. Cancers 14:11, pages 2602.
Crossref
Maria João Ramalho, Maria Bravo, Joana Angélica Loureiro, Jorge Lima & Maria Carmo Pereira. (2022) Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells. Life Sciences 296, pages 120435.
Crossref
Sukanya Bhunia & Arabinda Chaudhuri. 2022. Brain Tumors. Brain Tumors.
Bwalya Angel Witika, Madan Sai Poka, Patrick Hulisani Demana, Scott Kaba Matafwali, Siyabonga Melamane, Sandile Maswazi Malungelo Khamanga & Pedzisai Anotida Makoni. (2022) Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date. Pharmaceutics 14:4, pages 836.
Crossref
Yi-Shu Zhou, Wei Wang, Na Chen, Li-Cui Wang & Jin-Bai Huang. (2022) Research progress of anti-glioma chemotherapeutic drugs (Review). Oncology Reports 47:5.
Crossref
Maria João Ramalho, Joana Angélica Loureiro, Manuel A. N. Coelho & Maria Carmo Pereira. (2022) Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma. Pharmaceutics 14:2, pages 279.
Crossref
Mengmeng Liu, Xinmei Chen, Hang Chen, Xin Wu, Wei Fan & Jianming Chen. (2022) Nanotechnology-Based Drug Delivery System for Anticancer Active Ingredients from Traditional Chinese Medicines: A Review. The American Journal of Chinese Medicine 50:08, pages 2011-2032.
Crossref
Srinivas Reddy Jitta & Lalit Kumar. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors
269
297
.
Navya Ajitkumar Bhaskaran & Lalit Kumar. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors
237
268
.
Pearl Dighe. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors
205
233
.
Iara Baldim, Wanderley P. Oliveira, Rekha Rao, Singh Raghuvir, Sheefali Mahant, Francisco M. Gama & Eliana B. Souto. 2022. Nanoparticle Therapeutics. Nanoparticle Therapeutics
211
246
.
Muhammad Daniyal Ghouri, Jabran Saleem, Jiayu Ren, Jiaming Liu, Arsalan Umer, Rong Cai & Chunying Chen. (2021) Nanomaterials‐Mediated Structural and Physiological Modulation of Blood Brain Barrier for Therapeutic Purposes. Advanced Materials Interfaces 9:1.
Crossref
Kenichiro Asano, Toshio Fumoto, Masashi Matsuzaka, Seiko Hasegawa, Naoya Suzuki, Kenichi Akasaka, Kosuke Katayama, Akihisa Kamataki, Akira Kurose & Hiroki Ohkuma. (2021) Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma. BMC Cancer 21:1.
Crossref
Gustavo Henrique Rodrigues da Silva, Ludmilla David de Moura, Fabíola Vieira de Carvalho, Gabriela Geronimo, Talita Cesarim Mendonça, Fernando Freitas de Lima & Eneida de Paula. (2021) Antineoplastics Encapsulated in Nanostructured Lipid Carriers. Molecules 26:22, pages 6929.
Crossref
Leonardo Delello Di Filippo, Juliana Hofstätter Azambuja, Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Jonatas Lobato Duarte, Luiza Ribeiro Nicoleti, Sara Teresinha Olalla Saad & Marlus Chorilli. (2021) Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 76-89.
Crossref
Güliz Ak, Ayşe Ünal, Tuğba Karakayalı, Buket Özel, Nur Selvi Günel & Şenay Hamarat Şanlıer. (2021) Brain-targeted, drug-loaded solid lipid nanoparticles against glioblastoma cells in culture. Colloids and Surfaces B: Biointerfaces 206, pages 111946.
Crossref
Zając A, Sumorek-Wiadro J, Maciejczyk A, Langner E, Wertel I, Rzeski W & Jakubowicz-Gil J. (2021) LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death. Cell and Tissue Research 386:1, pages 17-28.
Crossref
Hamdi Nsairat, Dima Khater, Fadwa Odeh, Fedaa Al-Adaileh, Suma Al-Taher, Areej M. Jaber, Walhan Alshaer, Abeer Al Bawab & Mohammad S. Mubarak. (2021) Lipid nanostructures for targeting brain cancer. Heliyon 7:9, pages e07994.
Crossref
P. Soma Yasaswi, Karishma Shetty & Khushwant S. Yadav. (2021) Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy. Journal of Controlled Release 336, pages 549-571.
Crossref
Cristiane M. Pinto, Laila S. Horta, Amanda P. Soares, Bárbara A. Carvalho, Enio Ferreira, Eduardo B. Lages, Lucas A. M. Ferreira, André A. G. Faraco, Helton C. Santiago & Gisele A. C. Goulart. (2021) Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice. Pharmaceutics 13:7, pages 1021.
Crossref
Liying Wang, Xiangbo Wang, Lina Shen, Majed Alrobaian, Sunil K. Panda, Hussain A. Almasmoum, Mazen M. Ghaith, Riyad A. Almaimani, Ibrahim Abdel Aziz Ibrahim, Tanuja Singh, Abdullah A. Baothman, Hani Choudhry & Sarwar Beg. (2021) Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme. Biomedicine & Pharmacotherapy 138, pages 111461.
Crossref
Lisha Chang, Yunhe Zhang, Min Li, Xiaojing Zhao, Dali Wang, Jian Liu, Fuling Zhou & Jiang Zhang. (2021) Nanostructured lipid carrier co-delivering paclitaxel and doxorubicin restrains the proliferation and promotes apoptosis of glioma stem cells via regulating PI3K/Akt/mTOR signaling. Nanotechnology 32:22, pages 225101.
Crossref
T. I. Shlapakova, E. E. Tyagunova, R. K. Kostin & D. A. Danilova. (2021) Targeted Antitumor Drug Delivery to Glioblastoma Multiforme Cells. Russian Journal of Bioorganic Chemistry 47:2, pages 376-379.
Crossref
Bruna G. Carvalho, Franciele F. Vit, Hernandes F. Carvalho, Sang W. Han & Lucimara G. de la Torre. (2021) Recent advances in co-delivery nanosystems for synergistic action in cancer treatment. Journal of Materials Chemistry B 9:5, pages 1208-1237.
Crossref
Weiwei Ji & Zhilan Liu. (2021) Temozolomide-Loaded Solid Lipid Nanoparticles@Hydrogel for Local Treatment of Tumour. Australian Journal of Chemistry 74:2, pages 125.
Crossref
Ratnali Bania, Pobitra Borah, Satyendra Deka, Lina A. Dahabiyeh, Vinayak Singh, Nizar A. Al-Shar’i, Anroop B. Nair, Manoj Goyal, Katharigatta N. Venugopala, Rakesh Kumar Tekade & Pran Kishore Deb. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer
267
280
.
Nupur Shrivastava, Ankit Parikh, Aiswarya Chaudhuri, Javed Ali, Sanjula Baboota & Sanjay Garg. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs
259
305
.
Phoebe McCrorie, Catherine E. Vasey, Stuart J. Smith, Maria Marlow, Cameron Alexander & Ruman Rahman. (2020) Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma. Journal of Controlled Release 328, pages 917-931.
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2020) Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases. Journal of the Taiwan Institute of Chemical Engineers 114, pages 12-23.
Crossref
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sunil Kumar Dubey, Anu Puri, Ravish J. Patel, Ajazuddin, V. Ravichandiran, Upadhyayula Suryanarayana Murty & Amit Alexander. (2020) Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. Journal of Controlled Release 321, pages 372-415.
Crossref
C. Carbone, V. Fuochi, A. Zielińska, T. Musumeci, E.B. Souto, A. Bonaccorso, C. Puglia, G. Petronio Petronio & P.M. Furneri. (2020) Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis. Colloids and Surfaces B: Biointerfaces 186, pages 110705.
Crossref
Fakhara Sabir, Ruba Ismail & Ildiko Csoka. (2020) Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook. Drug Discovery Today 25:1, pages 185-194.
Crossref
Mónica Cristina García. 2020. Engineering Drug Delivery Systems. Engineering Drug Delivery Systems
71
110
.
Vishal Sharad Chaudhari, Prakash Kishore Hazam & Subham Banerjee. 2020. Sustainable Agriculture Reviews 44. Sustainable Agriculture Reviews 44
169
203
.
Michele d'Angelo, Vanessa Castelli, Elisabetta Benedetti, Andrea Antonosante, Mariano Catanesi, Reyes Dominguez-Benot, Giuseppina Pitari, Rodolfo Ippoliti & Annamaria Cimini. (2019) Theranostic Nanomedicine for Malignant Gliomas. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Raul Ortiz, Laura Cabeza, Gloria Perazzoli, Julia Jimenez-Lopez, Beatriz García-Pinel, Consolación Melguizo & Jose Prados. (2019) Nanoformulations for glioblastoma multiforme: a new hope for treatment. Future Medicinal Chemistry 11:18, pages 2461-2482.
Crossref
Bibhash C. Mohanta, Narahari N. Palei, Vijayaraj Surendran, Subas C. Dinda, Jayaraman Rajangam, Jyotirmoy Deb & Biswa M. Sahoo. (2019) Lipid Based Nanoparticles: Current Strategies for Brain Tumor Targeting. Current Nanomaterials 4:2, pages 84-100.
Crossref
Juhi Samal, Ana Lucia Rebelo & Abhay Pandit. (2019) A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders. Advanced Drug Delivery Reviews 148, pages 68-145.
Crossref
Vedanti R. Salvi & Pravin Pawar. (2019) Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology 51, pages 255-267.
Crossref
Alja Zottel, Alja Videtič Paska & Ivana Jovčevska. (2019) Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy. Materials 12:10, pages 1588.
Crossref
Hongzhi Zhang, Huijuan Jiang, Huixiang Zhang, Juncai Liu, Xigang Hu & Lei Chen. (2019) Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer. International Journal of Biological Macromolecules 128, pages 574-582.
Crossref
Alexandros Papachristodoulou, Rea Deborah Signorell, Beat Werner, Davide Brambilla, Paola Luciani, Mustafa Cavusoglu, Joanes Grandjean, Manuela Silginer, Markus Rudin, Ernst Martin, Michael Weller, Patrick Roth & Jean-Christophe Leroux. (2019) Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes. Journal of Controlled Release 295, pages 130-139.
Crossref
Berrin Küçüktürkmen & Asuman Bozkır. 2019. Nanoarchitectonics in Biomedicine. Nanoarchitectonics in Biomedicine
335
369
.
Saini Setua, Meena Jaggi, Murali M. Yallapu, Subhash C. Chauhan, Anna Danilushkina, Hojae Lee, Insung S. Choi, Rawil Fakhrullin, Lorenzo Degli Esposti, Anna Tampieri, Michele Iafisco, Maxim Shevtsov & Gabriele Multhoff. 2018. Nanotechnologies in Preventive and Regenerative Medicine. Nanotechnologies in Preventive and Regenerative Medicine
399
511
.
Narahari N. Palei, Bibhash C. Mohanta, Mohana L. Sabapathi & Malay K. Das. 2018. Organic Materials as Smart Nanocarriers for Drug Delivery. Organic Materials as Smart Nanocarriers for Drug Delivery
415
470
.
Maria J. Ramalho, Manuel A.N. Coelho & Maria C. Pereira. 2018. Design and Development of New Nanocarriers. Design and Development of New Nanocarriers
687
722
.
M.C. García, C. Aloisio, R. Onnainty & G. Ullio-Gamboa. 2018. Nanobiomaterials. Nanobiomaterials
41
94
.
Bing Xiao, Jianbin Li, Yanghua Fan, Minhua Ye, Shigang Lv, Bin Xu, Yi Chai, Zhiqing Zhou, Miaojing Wu & Xingen Zhu. (2017) Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis. Molecular Medicine Reports 16:6, pages 9017-9022.
Crossref
Masoumeh Mansoubi Hosseini, Aliasghar Karimi, Mitra Behroozaghdam, Mohammad Amin Javidi, Saeedeh Ghiasvand, Ahmad Bereimipour, Hoda Aryan, Farbod Nassiri & Ehsan Jangholi. (2017) Cytotoxic and Apoptogenic Effects of Cyanidin-3-Glucoside on the Glioblastoma Cell Line. World Neurosurgery 108, pages 94-100.
Crossref
Pablo Játiva & Valentín Ceña. (2017) Use of nanoparticles for glioblastoma treatment: a new approach. Nanomedicine 12:20, pages 2533-2554.
Crossref
Christos Tapeinos, Matteo Battaglini & Gianni Ciofani. (2017) Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. Journal of Controlled Release 264, pages 306-332.
Crossref
Saurabh Sharma, Kishan Italiya, Anupama Mittal & Deepak Chitkara. (2017) New strategies for cancer management: how can temozolomide carrier modifications improve its delivery?. Therapeutic Delivery 8:7, pages 475-477.
Crossref
Baomin Zhu, Lianling Yu & QingCai Yue. (2017) Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy. Biomedicine & Pharmacotherapy 91, pages 287-294.
Crossref
Yang-Hua Fan, Bing Xiao, Shi-Gang Lv, Min-Hua Ye, Xin-Gen Zhu & Miao-Jing Wu. (2017) Lentivirus-mediated knockdown of chondroitin polymerizing factor inhibits glioma cell growth in vitro. Oncology Reports 38:2, pages 1149-1155.
Crossref
Dazhong Chen, Fangyuan Xie, Duxin Sun, Chuan Yin, Jie Gao & Yanqiang Zhong. (2017) Nanomedicine-Mediated Combination Drug Therapy in Tumor. Open Pharmaceutical Sciences Journal 4:1, pages 1-10.
Crossref